Solventum (SOLV) Expected to Announce Quarterly Earnings on Thursday

Key Points

• Solventum (SOLV) is expected to announce its Q2 2025 earnings on August 7th, with projected earnings of $1.45 per share and anticipated revenue of $2.12 billion.
• The company's last earnings report on May 8th showed an EPS of $1.34, exceeding the analyst estimate of $1.19, along with a revenue increase of 2.7% year-over-year.
• Recent analyst ratings have seen upgrades from multiple firms, with a consensus rating of "Hold" and an average target price of $84.38 for Solventum shares.

Solventum (NYSE:SOLV - Get Free Report) will likely be releasing its Q2 2025 earnings data before the market opens on Thursday, August 7th. Analysts expect Solventum to post earnings of $1.45 per share and revenue of $2.12 billion for the quarter.

Solventum (NYSE:SOLV - Get Free Report) last announced its earnings results on Thursday, May 8th. The company reported $1.34 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.19 by $0.15. Solventum had a return on equity of 31.01% and a net margin of 4.55%. The company had revenue of $2.07 billion for the quarter, compared to analyst estimates of $2.02 billion. During the same period in the prior year, the company posted $2.08 EPS. The firm's quarterly revenue was up 2.7% compared to the same quarter last year. On average, analysts expect Solventum to post $7 EPS for the current fiscal year and $5 EPS for the next fiscal year.

Solventum Stock Up 0.5%

NYSE:SOLV traded up $0.37 during mid-day trading on Friday, hitting $71.73. 780,679 shares of the company's stock traded hands, compared to its average volume of 560,246. The company has a fifty day moving average of $74.17 and a 200 day moving average of $73.02. Solventum has a twelve month low of $54.26 and a twelve month high of $85.92. The company has a market capitalization of $12.41 billion, a P/E ratio of 33.21, a P/E/G ratio of 1.83 and a beta of 0.53. The company has a debt-to-equity ratio of 2.40, a quick ratio of 0.85 and a current ratio of 1.19.

Wall Street Analysts Forecast Growth

SOLV has been the topic of several recent analyst reports. Piper Sandler raised Solventum from a "neutral" rating to an "overweight" rating and upped their target price for the company from $78.00 to $87.00 in a research report on Monday, May 19th. KeyCorp initiated coverage on Solventum in a research report on Friday, June 6th. They set a "sector weight" rating on the stock. Argus raised Solventum from a "hold" rating to a "buy" rating and set a $90.00 target price on the stock in a research report on Tuesday, July 1st. Finally, Morgan Stanley raised Solventum from an "equal weight" rating to an "overweight" rating and increased their price objective for the company from $80.00 to $103.00 in a report on Tuesday, July 15th. One analyst has rated the stock with a sell rating, six have assigned a hold rating and four have assigned a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of "Hold" and an average target price of $84.38.

Institutional Trading of Solventum

A number of hedge funds have recently modified their holdings of SOLV. United Services Automobile Association purchased a new stake in shares of Solventum in the first quarter worth about $239,000. Woodline Partners LP boosted its position in Solventum by 40.7% during the first quarter. Woodline Partners LP now owns 11,677 shares of the company's stock worth $888,000 after purchasing an additional 3,377 shares in the last quarter. Finally, Intech Investment Management LLC boosted its position in Solventum by 167.0% during the first quarter. Intech Investment Management LLC now owns 16,669 shares of the company's stock worth $1,268,000 after purchasing an additional 10,425 shares in the last quarter.

About Solventum

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.